Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-24-003008
Filing Date
2024-03-27
Accepted
2024-03-27 16:19:33
Documents
20

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 2150556
2 filename2.htm EX-3.1 123793
3 filename3.htm EX-3.3 70252
4 filename4.htm EX-4.2 184870
5 filename5.htm EX-10.1 190761
6 filename6.htm EX-10.11 88977
7 filename7.htm EX-10.12 33975
8 filename8.htm EX-21.1 1694
9 GRAPHIC g803738g00m02.jpg GRAPHIC 41235
10 GRAPHIC g803738g00m26.jpg GRAPHIC 131536
11 GRAPHIC g803738g00m27.jpg GRAPHIC 137274
12 GRAPHIC g803738g00m28.jpg GRAPHIC 68766
13 GRAPHIC g803738g00m29.jpg GRAPHIC 88457
14 GRAPHIC g803738g00m30.jpg GRAPHIC 83752
15 GRAPHIC g803738g00m31.jpg GRAPHIC 85257
16 GRAPHIC g803738g00m33.jpg GRAPHIC 145393
17 GRAPHIC g803738g00s30.jpg GRAPHIC 93961
18 GRAPHIC g803738g25c41.jpg GRAPHIC 200531
19 GRAPHIC g803738g35h11.jpg GRAPHIC 140018
20 GRAPHIC g803738g56a01.jpg GRAPHIC 81756
  Complete submission text file 0000950123-24-003008.txt   4590492
Mailing Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215 857-321-8020
Rapport Therapeutics, Inc. (Filer) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-07153 | Film No.: 24790880
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)